Position in RYTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,466,593
+$540,190 QoQ
Shares Held
13,209
+24.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#145
of 299 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Derivatives in RYTM
reported options exposure · as of Jun 30, 2024CallValue
$229,936
CallShares
5,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. RYTM ranks #95 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in RYTM
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,466,593 | 13,209 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $926,403 | 10,652 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,068,908 | 131,436 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,379,460 | 142,385 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $22,192,200 | 351,198 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $5,361,463 | 101,217 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $7,579,524 | 135,397 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $5,574,138 | 106,397 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $229,936 | 5,600 | Call | Sole | 2026-03-23 | |
| 2024-06-30 | $2,202,088 | 53,631 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $5,526,134 | 127,536 | Shares | Sole | 2026-03-24 | |
| 2024-03-31 | $242,648 | 5,600 | Call | Sole | 2026-03-24 | |
| 2023-12-31 | $11,557,547 | 251,415 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $257,432 | 5,600 | Call | Sole | 2026-03-24 | |
| 2023-09-30 | $5,530,908 | 241,261 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $2,147,459 | 130,228 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,554,184 | 87,118 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $5,317,282 | 182,599 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $4,026,648 | 164,353 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $38,553 | 9,290 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $244,212 | 21,199 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $533,620 | 53,469 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $460,939 | 35,294 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $361,994 | 18,488 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,579,998 | 74,283 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,033,295 | 34,756 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,104,698 | 97,125 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,271,277 | 101,851 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,426,479 | 93,724 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||